Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining 2.55% today. In the last week its performance is 3.08%, and 8.19% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 167.06, so today’s gain of 2.55% is a significant step towards its target price. The GAP today is therefore 0.56%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 29958.46, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 98.30%.

At the current price of 133.69, it has a dividend yield of *TBA, and its target price is 167.06. This is with a profit margin of 3.20%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 338.46, as well as a forward P/E of 22.6.

With a current EPS of 0.4, and a forecasted EPS growth for next year at 27.36%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.28%.

Performance for the year is -16.25%. Since its IPO date on 2/28/1996, the total performance to date is -29.91%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 1173400, while its average volume is 1713.09. Whilst the total gain today was 2.55%, it did have a day high of -3.40%.

Volatility for this week has been at 2.82%, and 3.06% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 20.92%, while the 52-week-high has reached -30.89%.

Looking at its return of investments, which is 1.60%, and its return on assets is 0.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 21.70%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.39, and has a current ratio of 3.6 and 3.1 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 18.51, and the P/S is 10.62, along with a P/B of 3.65. Meanwhile it has a p/cash of 25.39.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment